Eli Lilly Cuts Insulin Prices After Public and Political Backlash

Drug manufacturer Eli Lilly cuts insulin prices after public and political backlash. Insurtech Bright Health tells investors it needs to raise $300 million to stay afloat. And, greater numbers of younger people are being diagnosed with advanced cases of colorectal cancers, according to a new study. That's coming up on today's episode of Gist Healthcare Daily.

Hosted on Acast. See acast.com/privacy for more information.